- Home
- AB vs ICUI Comparison
AB vs ICUI Comparison
Compare AB & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AB
- ICUI
- Stock Information
- Founded
- AB 1987
- ICUI 1984
- Country
- AB United States
- ICUI United States
- Employees
- AB N/A
- ICUI N/A
- Industry
- AB Investment Managers
- ICUI Medical/Dental Instruments
- Sector
- AB Finance
- ICUI Health Care
- Exchange
- AB Nasdaq
- ICUI Nasdaq
- Market Cap
- AB 4.0B
- ICUI 4.0B
- IPO Year
- AB 1988
- ICUI 1992
- Fundamental
- Price
- AB $34.52
- ICUI $179.51
- Analyst Decision
- AB Strong Buy
- ICUI Buy
- Analyst Count
- AB 5
- ICUI 4
- Target Price
- AB $39.95
- ICUI $149.00
- AVG Volume (30 Days)
- AB 201.2K
- ICUI 228.6K
- Earning Date
- AB 10-24-2024
- ICUI 11-04-2024
- Dividend Yield
- AB 8.21%
- ICUI N/A
- EPS Growth
- AB 26.36
- ICUI N/A
- EPS
- AB 2.88
- ICUI N/A
- Revenue
- AB N/A
- ICUI $2,304,277,000.00
- Revenue This Year
- AB N/A
- ICUI $3.80
- Revenue Next Year
- AB $6.99
- ICUI $4.01
- P/E Ratio
- AB $12.01
- ICUI N/A
- Revenue Growth
- AB N/A
- ICUI 0.46
- 52 Week Low
- AB $25.83
- ICUI $78.28
- 52 Week High
- AB $35.67
- ICUI $181.33
- Technical
- Relative Strength Index (RSI)
- AB 55.83
- ICUI 80.08
- Support Level
- AB $32.93
- ICUI $160.74
- Resistance Level
- AB $34.75
- ICUI $167.78
- Average True Range (ATR)
- AB 0.59
- ICUI 5.16
- MACD
- AB 0.04
- ICUI 0.50
- Stochastic Oscillator
- AB 79.10
- ICUI 91.83
About AB AllianceBernstein Holding L.P.
AllianceBernstein provides investment management services to institutional (42% of assets under management), retail (41%), and private (17%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of July 2024, AB had $777 billion in managed assets, composed primarily of fixed-income (37% of AUM) and equity (43%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder.
About ICUI ICU Medical Inc.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.